article thumbnail

Personalizing the Cancer Patient Journey

Pharma Marketing Network

Communication needs to be welcoming, relevant, and digestible. Patient centricity is informed by empathy and an understanding of the patient journey and the many factors that affect the patient experience along the continuum. Personalization means the customer feels as if someone is speaking directly to them. Accessed June 18, 2022.

article thumbnail

Cheryl Barton

pharmaphorum

In 2002, Dr Barton founded PharmaVision to provide independent, tailor-made, life sciences, and consumer health research to pharmaceutical companies, competitive intelligence specialists, investment institutions, and healthcare communication agencies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Porterhouse Medical Group joins imc group

pharmaphorum

Porterhouse Medical Group has joined up with imc (integrated medhealth communication) group, a healthcare communications and consulting agency. The post Porterhouse Medical Group joins imc group appeared first on.

article thumbnail

Healthware Group announces acquisition of Argon Global Healthcare network

pharmaphorum

” Established in 2002, Argon Global Healthcare has built a global healthcare agency network covering major markets in EMEA, Americas, and APAC. This robust network comprises independently owned healthcare communications agencies with a proven track record of high performance.

article thumbnail

Achieving scale up success under economic uncertainty

European Pharmaceutical Review

2 By comparison, the American Society of Health-System Pharmacists (ASHP) identified only 224 drug shortages during the entire six-year period between January 1996 and June 2002. Having an effective risk management model requires open communication, full transparency and speedy decision-making.

article thumbnail

Three strategies for managing loss of exclusivity successfully

pharmaphorum

6 The stakes were extremely high, with annual costs of insulin reaching $736 per patient in 2013, up threefold since 2002. RESULT: As of 2002, 40% of PRILOSEC patients had switched to NEXIUM, which notched up sales of $3.9 Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. billion in 2004.14

article thumbnail

A history of Johnson & Johnson

pharmaphorum

The company has also faced claims that it did not adequately communicate the risks of its opioid painkillers in its marketing, contributing to the US’ ‘opioid epidemic’, and that its talc products could contain small amounts of asbestos and lead to cancer. Weldon became the Chairman and CEO of J&J in 2002.

Vaccines 124